Privia Health Group, Inc. beat EPS estimates 38% of the time across 16 reported quarters (6 beats, 10 misses), averaging -7.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.08 | $0.07 | -12.5% | Miss | Q2 FY26 call |
| Q1 FY26 | not reported | $0.02 | not reported | not reported | |
| Q4 FY25 | $0.04 | $0.07 | +75.0% | Beat | Q4 FY25 call |
| Q3 FY25 | $0.06 | $0.05 | -16.7% | Miss | |
| Q2 FY25 | $0.05 | $0.02 | -60.0% | Miss | |
| Q1 FY25 | $0.06 | $0.03 | -50.0% | Miss | |
| Q4 FY24 | $0.06 | $0.03 | -50.0% | Miss | |
| Q3 FY24 | $0.06 | $0.03 | -50.0% | Miss | |
| Q2 FY24 | $0.05 | $0.03 | -40.0% | Miss | |
| Q1 FY24 | $0.05 | $0.02 | -60.0% | Miss | |
| Q4 FY23 | $0.05 | $0.02 | -60.0% | Miss | |
| Q3 FY23 | $0.06 | $0.05 | -16.7% | Miss |
Back to PRVA overview · PRVA holders · PRVA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.